UTHR earnings call for the period ending March 31, 2019.
News & Analysis: United Therapeutics
UTHR earnings call for the period ending December 31, 2018.
The company moved to immediately monetize a promising drug candidate. For a cool $800 million up-front payment, investors can't complain.
UTHR earnings call for the period ending September 30, 2018.
A new collaboration is funneling tens of millions of dollars onto the diabetes company’s balance sheet.
Shares soar for the second day in a row. What can explain the bullish move?
Shares are soaring following the company's announcement of a new partnership agreement. Here's what investors need to know.
These stocks are definitely inexpensive. But are they buys?
These stocks led the way higher. Find out why.
The niche biopharma announced that a trial will run through completion, but investors were hoping for better.